 Betsy Risendal
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 18 | 2023 | 2701 | 2.020 |
Why?
| | Cancer Survivors | 5 | 2023 | 289 | 1.800 |
Why?
| | Patient Navigation | 4 | 2022 | 84 | 1.770 |
Why?
| | Survivors | 12 | 2015 | 500 | 1.510 |
Why?
| | Breast Neoplasms | 23 | 2022 | 2294 | 1.290 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 803 | 1.190 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 157 | 0.780 |
Why?
| | Delivery of Health Care | 8 | 2023 | 960 | 0.690 |
Why?
| | Health Plan Implementation | 3 | 2018 | 142 | 0.680 |
Why?
| | Early Detection of Cancer | 7 | 2023 | 432 | 0.600 |
Why?
| | Patient Care Planning | 4 | 2015 | 150 | 0.540 |
Why?
| | Patient Advocacy | 1 | 2017 | 76 | 0.510 |
Why?
| | Quality of Life | 4 | 2023 | 2954 | 0.450 |
Why?
| | Specialization | 1 | 2015 | 148 | 0.430 |
Why?
| | Research Design | 4 | 2025 | 1120 | 0.390 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 225 | 0.380 |
Why?
| | Registries | 2 | 2020 | 2051 | 0.380 |
Why?
| | Self Care | 1 | 2014 | 383 | 0.360 |
Why?
| | Health Equity | 2 | 2023 | 99 | 0.340 |
Why?
| | Humans | 55 | 2025 | 138651 | 0.330 |
Why?
| | Mass Screening | 6 | 2022 | 1287 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1368 | 0.320 |
Why?
| | Indians, North American | 3 | 1999 | 644 | 0.310 |
Why?
| | Chronic Disease | 2 | 2015 | 1800 | 0.310 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 672 | 0.310 |
Why?
| | Patient-Centered Care | 1 | 2014 | 545 | 0.310 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 5523 | 0.310 |
Why?
| | Weight Gain | 1 | 2013 | 538 | 0.300 |
Why?
| | Middle Aged | 29 | 2022 | 33792 | 0.290 |
Why?
| | Aged | 21 | 2022 | 24182 | 0.280 |
Why?
| | Program Evaluation | 4 | 2022 | 911 | 0.280 |
Why?
| | Family Health | 1 | 2008 | 195 | 0.270 |
Why?
| | Logistic Models | 10 | 2019 | 2088 | 0.270 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 282 | 0.270 |
Why?
| | Surveys and Questionnaires | 9 | 2022 | 5868 | 0.260 |
Why?
| | Safety-net Providers | 2 | 2018 | 117 | 0.260 |
Why?
| | Quality of Health Care | 1 | 2011 | 651 | 0.250 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1310 | 0.250 |
Why?
| | Capacity Building | 2 | 2023 | 61 | 0.240 |
Why?
| | Case-Control Studies | 7 | 2020 | 3581 | 0.240 |
Why?
| | Female | 36 | 2025 | 73913 | 0.240 |
Why?
| | Mammography | 3 | 2010 | 159 | 0.230 |
Why?
| | Intergenerational Relations | 1 | 2025 | 23 | 0.230 |
Why?
| | Primary Health Care | 4 | 2022 | 1775 | 0.230 |
Why?
| | Survivorship | 2 | 2022 | 51 | 0.220 |
Why?
| | Odds Ratio | 5 | 2013 | 1084 | 0.220 |
Why?
| | Arizona | 4 | 2013 | 80 | 0.220 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 290 | 0.210 |
Why?
| | Adult | 25 | 2019 | 38296 | 0.200 |
Why?
| | Child Behavior | 1 | 2025 | 247 | 0.190 |
Why?
| | Exercise | 1 | 2014 | 2074 | 0.190 |
Why?
| | Risk Factors | 13 | 2023 | 10398 | 0.170 |
Why?
| | Healthcare Disparities | 3 | 2017 | 660 | 0.170 |
Why?
| | United States | 14 | 2023 | 15018 | 0.170 |
Why?
| | Papanicolaou Test | 1 | 1999 | 44 | 0.160 |
Why?
| | Vaginal Smears | 1 | 1999 | 61 | 0.160 |
Why?
| | Health Priorities | 1 | 1999 | 43 | 0.150 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2531 | 0.150 |
Why?
| | Unemployment | 1 | 2019 | 42 | 0.150 |
Why?
| | Research | 3 | 2018 | 452 | 0.150 |
Why?
| | Patient Education as Topic | 2 | 2014 | 763 | 0.140 |
Why?
| | Congresses as Topic | 1 | 2019 | 227 | 0.140 |
Why?
| | Age Factors | 7 | 2019 | 3274 | 0.130 |
Why?
| | Preventive Medicine | 1 | 2017 | 40 | 0.130 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5160 | 0.130 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 233 | 0.120 |
Why?
| | Public Health | 1 | 2021 | 582 | 0.120 |
Why?
| | Health Planning | 1 | 2015 | 47 | 0.120 |
Why?
| | Comorbidity | 1 | 2020 | 1655 | 0.110 |
Why?
| | Health Status | 1 | 2020 | 820 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 592 | 0.110 |
Why?
| | Community Health Centers | 1 | 2014 | 62 | 0.110 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 111 | 0.110 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 18 | 0.110 |
Why?
| | Transition to Adult Care | 1 | 2015 | 90 | 0.110 |
Why?
| | Disease Management | 2 | 2015 | 620 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 97 | 0.100 |
Why?
| | Health Behavior | 1 | 1999 | 776 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 855 | 0.100 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 246 | 0.100 |
Why?
| | Body Weight | 2 | 2013 | 990 | 0.100 |
Why?
| | Health Promotion | 2 | 2023 | 745 | 0.100 |
Why?
| | Colorado | 4 | 2025 | 4528 | 0.100 |
Why?
| | Age of Onset | 2 | 2019 | 519 | 0.100 |
Why?
| | New Mexico | 1 | 2013 | 93 | 0.100 |
Why?
| | Genetic Testing | 1 | 2015 | 457 | 0.100 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 440 | 0.100 |
Why?
| | Vitamin B Complex | 1 | 2013 | 42 | 0.100 |
Why?
| | Incidence | 4 | 2019 | 2830 | 0.100 |
Why?
| | Medical Oncology | 1 | 2015 | 303 | 0.100 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 33 | 0.100 |
Why?
| | Methionine | 1 | 2013 | 162 | 0.090 |
Why?
| | Male | 8 | 2025 | 68216 | 0.090 |
Why?
| | Folic Acid | 1 | 2013 | 188 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 724 | 0.090 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1310 | 0.090 |
Why?
| | Prognosis | 3 | 2022 | 4015 | 0.090 |
Why?
| | Health Services Accessibility | 2 | 2014 | 999 | 0.090 |
Why?
| | Patient Participation | 1 | 2014 | 426 | 0.090 |
Why?
| | Obesity | 3 | 2013 | 2994 | 0.080 |
Why?
| | Guideline Adherence | 1 | 2015 | 552 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2015 | 679 | 0.080 |
Why?
| | Feasibility Studies | 1 | 2014 | 970 | 0.080 |
Why?
| | Survival Rate | 2 | 2011 | 1932 | 0.080 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 36 | 0.080 |
Why?
| | Southwestern United States | 4 | 2011 | 93 | 0.080 |
Why?
| | Hydroxyestrones | 1 | 2009 | 2 | 0.080 |
Why?
| | Interviews as Topic | 2 | 2013 | 803 | 0.080 |
Why?
| | Patient Care Team | 1 | 2014 | 640 | 0.070 |
Why?
| | Cohort Studies | 2 | 2022 | 5729 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2008 | 336 | 0.070 |
Why?
| | Urinary Incontinence | 1 | 2008 | 66 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 324 | 0.070 |
Why?
| | Prospective Studies | 2 | 2025 | 7639 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1551 | 0.060 |
Why?
| | Parity | 2 | 2022 | 126 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2368 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1497 | 0.060 |
Why?
| | Patient Compliance | 1 | 2009 | 599 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3311 | 0.060 |
Why?
| | Psychometrics | 2 | 2018 | 726 | 0.050 |
Why?
| | Smoking | 2 | 2023 | 1607 | 0.050 |
Why?
| | Phenotype | 1 | 2011 | 3160 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1236 | 0.050 |
Why?
| | School Teachers | 1 | 2022 | 27 | 0.050 |
Why?
| | Parenting | 1 | 2025 | 315 | 0.040 |
Why?
| | Young Adult | 4 | 2019 | 13322 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2513 | 0.040 |
Why?
| | Child Development | 1 | 2025 | 471 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 345 | 0.040 |
Why?
| | Financing, Personal | 1 | 2019 | 28 | 0.040 |
Why?
| | Alcohol Drinking | 2 | 2011 | 819 | 0.040 |
Why?
| | School Health Services | 1 | 2022 | 226 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 1055 | 0.040 |
Why?
| | Culture | 1 | 1999 | 131 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1285 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 735 | 0.040 |
Why?
| | Minority Groups | 1 | 2000 | 274 | 0.040 |
Why?
| | Health Education | 1 | 2022 | 355 | 0.040 |
Why?
| | Body Mass Index | 3 | 2013 | 2385 | 0.040 |
Why?
| | Schools | 1 | 2022 | 462 | 0.040 |
Why?
| | Child | 4 | 2025 | 21883 | 0.040 |
Why?
| | Risk | 2 | 2012 | 912 | 0.040 |
Why?
| | Menopause | 2 | 2011 | 326 | 0.030 |
Why?
| | Postmenopause | 2 | 2009 | 376 | 0.030 |
Why?
| | Pregnancy | 3 | 2022 | 6836 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 294 | 0.030 |
Why?
| | Medicaid | 1 | 2021 | 447 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 59 | 0.030 |
Why?
| | Patient Selection | 1 | 2000 | 692 | 0.030 |
Why?
| | Cost of Illness | 1 | 2019 | 308 | 0.030 |
Why?
| | Risk-Taking | 1 | 1999 | 345 | 0.030 |
Why?
| | Data Collection | 2 | 2014 | 663 | 0.030 |
Why?
| | Urban Population | 1 | 1999 | 481 | 0.030 |
Why?
| | Child, Preschool | 2 | 2025 | 11130 | 0.030 |
Why?
| | Health Care Costs | 1 | 1999 | 418 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 296 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 405 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 308 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 785 | 0.030 |
Why?
| | Prejudice | 1 | 2015 | 72 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 406 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 43 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2015 | 139 | 0.030 |
Why?
| | Poverty Areas | 1 | 2014 | 40 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 523 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 187 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 233 | 0.030 |
Why?
| | Insurance, Health | 1 | 2015 | 295 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 362 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2744 | 0.020 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 48 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 57 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7683 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 494 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 21528 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 480 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 351 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 132 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 355 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1376 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 696 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 103 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 944 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 95 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 525 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 554 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 830 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 371 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 715 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3459 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 457 | 0.020 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 321 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 15860 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 65 | 0.010 |
Why?
| | Language | 1 | 2000 | 302 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|